-praxair, then you have air products and chemicals.you're talking about companies that size, that is it. mark: what about antitrust issues, oliver? will this face scrutiny? will it get the approval of antitrust officials? oliver: you know, i can't say that for sure. i'm not sure anyone can. look at they did make politically sensitive decisions. they are basing this company in denver and germany. they're pushing the idea that this is not just a u.s. company, andxists in the u.s. germany. when it comes to antitrust regulations, they are going to look at those moves. mark: things for joining us praxair merger of equals, or is it? julie: glad to know we got the same lesson at bloomberg, mark. and out judge professor of the hedge fund in the street, it took hits in 2016, but was it that horrific? more on the most read story next. we continue to watch the dow to see if it is getting us to 20,000. still hovering around levels just shy of 40 points away. he will keep watching it. this is bloomberg. ♪ julie: you are watching bloomberg. i am jul

linde revived talks after praxair provided new assurances over jobs. they created the biggest oil and gas company. linde denies the reports. >>> and braas monier and standard industries have been involved in a legal dispute. but standard industries prompted to reach a merger deal out of court instead. >>> and this weekend in madrid some 10,000 runners dressed as santa clause or his elves taking part in the annual fund-raiser. that's a lot of santas. the sea of red ran through the streets of the spanish capital to raise money for spain's multiple sclerosis. society -- don't bring your kids to something like that if they are under, what, 5? they will be scarred for life because there's supposed to be just one santa. >>> e-mail the show to get your questions or comments through. the address is streetsignseurope@cnbc.com. if you can't cut the 140 characters on twitter, you can find us on twitter as well at @streetsignscnbc. tweet me @louisaboys bojesen. it's fantastic to have you here on this monday. we'll be right back. >>> hi, everybody. welcome back to

and praxair holders would get one share for the shares they own.holders still need to give approval. >>> square was rated buy at instinet. has been countrily gaining share. stock is higher 1.5% in the premarket. >>> let's get back to guest host martin franklin. rising interest rates in the wake of the election. let's talk about their impact. we talk about it on this network whether it's mortgage rates, whether the ability to borrow from corporations. the turmoil it's describing overseas, what do you think about it? >> that's probably the choppiest water for continued growth. because at the end of the day, it can dampen consumer demand. it's a question of pace. i think the idea that next year there are going to be three, maybe four fed increases, a question of degree, you know, it's all sentiment. i think people who have refinanced all their mortgages over the last five years and all have more disposal incomes. people can afford to pay less for their homes. it's that simple. >> yes. everybody's very focused on the fed and how many next year, but it

praxair fell to $118.39. >>> and blackberry raised after beating analysts' expectations.did report worse than expected sales as demand continues to fall. shares were off more than 2.5% to $7.50. >>> a group of democratic senators has sent a letter to president-elect trump on the issue of drug prices. the senators led by sheriff brown and al franken said there is the posititential for bipart reform. including allowing medicare to negotiate prescription drug prices, stopping abusive pricing practices and supporting generic competition for branded drugs. >>> since the election, health care industry has been hit with an awful lot of uncertainty surrounding the fate of the affordable care act. the sector has only risen 1% since the election. much less than the broader market. it is down nearly 4% for the year. so will 2017 bring clarity in investing opportunity in the health care sector. joining us is the health care policy expert at capital street. nice to have you back. >> thank you. >> let's start -- first of all, last time you joined us, you said it was about a lack of cla

lind out of germany reaching a deal with praxair, lower on that news. a lot going on, all involved in dow 20,000 and see whether or not we make it this hour or we have to wait for, you know, maybe tomorrow. we start you off at the floor show. traders here at the new york stock exchange and the cme group, alan is here with me in new york. alan knuckman out of chicago, scott shellady is in new york. trust me, we know we do too much of this. hype up round numbers, okay? let's get that out of the way. i'll speak for the media as a whole, what does it mean the idea of dow 20,000 after an election and everything else. >> a big psychological number, and we're going to break it. >> yeah, it's a matter of time. >> a matter of time. we could see it tomorrow or thursday, we have no government data today, we have earnings coming up, after the bell, fedex after the bell. they're coming out after. not going to affect the close. thursday home sales and a slew of government information data, that could definitely move the market on the opening alone. i think we see it